FDA Drug recall D-0131-2020
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, I…
- FDA Drug
- Class III
- terminated
- Published 2019-10-16
On 2019-10-16 the FDA classified a Class III recall of Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, I… by Teva Pharmaceuticals Usa, citing GMP Deviation: lot not intended for commercial distribution.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0131-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-09-06 |
| Published | 2019-10-16 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30
Reason
GMP Deviation: lot not intended for commercial distribution.
Identifiers
| ndc | 52544-691-30 |
|---|---|
| ndc | 52544-691-19 |
| ndc | 52544-691-10 |
| ndc | 52544-692-30 |
| ndc | 52544-692-19 |
| ndc | 52544-692-10 |
| ndc | 52544-693-30 |
| ndc | 52544-693-19 |
| ndc | 52544-693-10 |
| ndc | 52544-694-30 |
| ndc | 52544-694-19 |
| ndc | 52544-694-10 |
| ndc | 52544-695-30 |
| ndc | 52544-695-19 |
| ndc | 52544-695-10 |
| code_info | Lot # 1344864A, exp. date 10/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0131-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.